Publication number: 20190228844
Abstract: An evaluating method includes an evaluating step of evaluating a state of colorectal cancer for a subject to be evaluated using (i) a concentration value of at least one metabolite of bABA, N-Me-bABA, 1-Me-His, aABA, Aminoadipic acid, bAiBA, Cadaverine, Ethylglycine, GABA, Homoarginine, Hypotaurine, Kinurenine, N6-Acetyl-L-Lys, Putrescine, Serotonin, Spermidine, Spermine, ADMA, Homocitrulline, 3-Me-His, Hydroxyproline, Phosphoethanolamine, SDMA, Acylcarnitine (13:1), and EPA in blood of the subject or (ii) a value of a formula calculated using the concentration value of the metabolite and the formula including an explanatory variable to be substituted with the concentration value of the metabolite.
Type:
Application
Filed:
April 2, 2019
Publication date:
July 25, 2019
Applicant:
AJINOMOTO CO., INC.
Inventors:
Hidehiro NAKAMURA, Natsumi NISHIKATA, Akira IMAIZUMI, Kazutaka SHIMBO, Naoko ARASHIDA, Rumi NISHIMOTO
Publication number: 20190227071
Abstract: An evaluating method includes an evaluating step of evaluating a state of pancreatic cancer for a subject to be evaluated using (i) a concentration value of at least one metabolite of N-Me-bABA, bABA, GABA, N6-Acetyl-L-Lys, 1-Me-His, aABA, Aminoadipic acid, bAiBA, Cadaverine, Ethylglycine, Homoarginine, Hypotaurine, Kinurenine, Putrescine, Serotonin, Spermidine, Spermine, ADMA, Homocitrulline, 3-Me-His, Hydroxyproline, Phosphoethanolamine, Acylcarnitine (13:1), and EPA in blood of the subject or (ii) a value of a formula calculated using the concentration value of the metabolite and the formula including an explanatory variable to be substituted with the concentration value of the metabolite.
Type:
Application
Filed:
April 2, 2019
Publication date:
July 25, 2019
Applicant:
AJINOMOTO CO., INC.
Inventors:
Hidehiro NAKAMURA, Natsumi NISHIKATA, Akira IMAIZUMI, Kazutaka SHIMBO, Naoko ARASHIDA, Rumi NISHIMOTO